Diatech Pharmacogenetics

Diatech Pharmacogenetics is a commercial-stage diagnostics company specializing in molecular testing for precision medicine in oncology and pharmacogenetics. Leveraging over 25 years of collective experience, the company executes over 500,000 tests annually worldwide and is ISO 9001, ISO 13485, and EU IVDR certified, indicating a strong focus on quality and regulatory compliance. Its core value proposition is delivering timely, actionable genetic information to clinicians to guide therapeutic selection, aiming to improve patient outcomes by ensuring 'the right drug, for the right patient, at the right time.' The company operates as a private entity, driving adoption through its testing services, educational webinars, and a knowledge hub for the medical community.

Integrated molecular testing and clinical interpretation service utilizing established techniques (e.g., PCR, NGS) within an ISO 13485/EU IVDR-certified laboratory framework, focused on actionable biomarkers in oncology and pharmacogenetics.

Diatech competes in a crowded molecular diagnostics market against large, diversified players like Roche, Qiagen, and Thermo Fisher, as well as other specialized reference laboratories and hospital labs. Its differentiation is based on a focused menu in oncology/pharmacogenetics, high test volume scale, EU IVDR compliance, and a strong clinical education focus. Competition is based on test accuracy, turnaround time, cost, menu breadth, and clinical utility.